Yossi Maimon
2007 - Protalix BioTherapeutics
In 2007, Yossi Maimon earned a total compensation of $523.5K as Chief Financial Officer at Protalix BioTherapeutics, a 218% increase compared to previous year.
Compensation breakdown
| Bonus | $77,223 |
|---|---|
| Option Awards | $247,815 |
| Salary | $156,444 |
| Other | $41,975 |
| Total | $523,457 |
Maimon received $247.8K in option awards, accounting for 47% of the total pay in 2007.
Maimon also received $77.2K in bonus, $156.4K in salary and $42K in other compensation.
Rankings
In 2007, Yossi Maimon's compensation ranked 5,933rd out of 8,700 executives tracked by ExecPay. In other words, Maimon earned more than 31.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,933 out of 8,700 | 32nd |
Division Manufacturing | 2,236 out of 3,314 | 33rd |
Major group Chemicals And Allied Products | 487 out of 746 | 35th |
Industry group Drugs | 335 out of 546 | 39th |
Industry Biological Products, Except Diagnostic Substances | 62 out of 118 | 48th |
Source: SEC filing on September 17, 2009.
Maimon's colleagues
We found four more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2007.